The inhibitory effects of Wnt signaling pathway by nonsteroidal anti-inflammatory drugs and valproic acid has been used as adjuvant for HCC therapy [8], therefore, CTNNB1 inhibitors become the new study direction in preventing precancerous lesions such as hepatitis and liver cirrhosis from deteriorating. The gene discussed is CTNNB1; the disease is hepatocellular carcinoma.